← Open Payments lookup

JAMIE BROCKMAN: Open Payments

NPI 1053075820 · SURPRISE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,706 in 77 payments from 15 companies in 2025. Trend: 2023 $374 · 2024 $1,302 · 2025 $1,706

Food & beverage: $1,706
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP12$356
Lilly USA, LLC12$187
Amgen Inc.15$187
Novo Nordisk Inc4$173
ABBVIE INC.9$163
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$163
Sumitomo Pharma America, Inc.4$101
Abbott Laboratories4$90
Merck Sharp & Dohme LLC3$61
Boston Scientific Corporation2$59

Products named: AIRSUPRA, CAPLYTA, Ozempic, FARXIGA, GEMTESA, MOUNJARO, REPATHA, OTEZLA.

Industry payments across AZ — which companies pay providers there.